Cosmo Pharmaceuticals SpA, the Italian developer of gastro-intestinal (GI) drugs, said its revenue rose 44.5% in 2007 to €21.9 million, helping it to generate a net profit of €0.1 million compared with a loss of €0.3 million in 2006. ---Subscribe to MedNous to access this article--- Company News
